- Home
- PMVP vs MATH Comparison
PMVP vs MATH Comparison
Compare PMVP & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- MATH
- Stock Information
- Founded
- PMVP 2013
- MATH 2015
- Country
- PMVP United States
- MATH Hong Kong
- Employees
- PMVP N/A
- MATH N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- MATH Finance/Investors Services
- Sector
- PMVP Health Care
- MATH Finance
- Exchange
- PMVP Nasdaq
- MATH Nasdaq
- Market Cap
- PMVP 55.1M
- MATH 60.8M
- IPO Year
- PMVP 2020
- MATH N/A
- Fundamental
- Price
- PMVP $1.09
- MATH $3.30
- Analyst Decision
- PMVP Strong Buy
- MATH
- Analyst Count
- PMVP 1
- MATH 0
- Target Price
- PMVP $5.00
- MATH N/A
- AVG Volume (30 Days)
- PMVP 362.7K
- MATH 346.2K
- Earning Date
- PMVP 08-07-2025
- MATH 01-01-0001
- Dividend Yield
- PMVP N/A
- MATH N/A
- EPS Growth
- PMVP N/A
- MATH N/A
- EPS
- PMVP N/A
- MATH 0.17
- Revenue
- PMVP N/A
- MATH $31,399,049.00
- Revenue This Year
- PMVP N/A
- MATH N/A
- Revenue Next Year
- PMVP N/A
- MATH N/A
- P/E Ratio
- PMVP N/A
- MATH $20.38
- Revenue Growth
- PMVP N/A
- MATH 291.58
- 52 Week Low
- PMVP $0.81
- MATH $0.80
- 52 Week High
- PMVP $1.82
- MATH $4.17
- Technical
- Relative Strength Index (RSI)
- PMVP 61.16
- MATH 51.81
- Support Level
- PMVP $1.01
- MATH $2.72
- Resistance Level
- PMVP $1.12
- MATH $4.17
- Average True Range (ATR)
- PMVP 0.07
- MATH 0.39
- MACD
- PMVP 0.01
- MATH -0.11
- Stochastic Oscillator
- PMVP 64.00
- MATH 34.83
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.